| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.72B | +7.3% | +31.5% |
| Cost of Revenue | $539.0M | -10.9% | +9.6% |
| R&D Expense | $320.0M | +5.6% | +28.0% |
| SG&A Expense | $456.0M | +2.0% | +26.7% |
| Operating Income | $407.0M | +64.1% | +96.6% |
| Pre-tax Income | $418.0M | +111.1% | +30.6% |
| Income Tax | $69.0M |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.41B | +10.7% | -22.6% |
| Accounts Receivable | $1.02B | +11.8% | +37.4% |
| Inventory | $1.04B | -1.0% | +1.2% |
| Current Assets | $5.04B | +7.3% | -7.8% |
| Total Assets | $11.74B | +2.2% | +11.4% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $942.0M | +113.6% | — |
| Capital Expenditures | $63.0M | +85.3% | — |
| Investing Cash Flow | -$80.0M | -81.8% | — |
| Financing Cash Flow | -$328.0M | -231.3% | — |
| Free Cash Flow | $879.0M | +116.0% | — |
| +183.1% |
| +9.5% |
| Net Income | $349.0M | +24.2% | +35.8% |
| EPS (Basic) | $2.04 | +24.4% | +36.9% |
| EPS (Diluted) | $2.02 | +23.9% | +35.6% |
| $2.65B |
| +46.8% |
| +64.1% |
| Long-term Debt | $2.53B | -0.1% | -0.0% |
| Total Liabilities | $5.41B | +2.5% | +6.9% |
| Stockholders' Equity | $6.33B | +2.0% | +15.6% |